R Squared’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
2,817
+246
+10% +$25.2K 0.14% 257
2026
Q1
$281K Sell
2,571
-59
-2% -$5.62K 0.15% 221
2025
Q4
$213K Sell
2,630
-503
-16% -$43.3K 0.1% 339
2025
Q3
$274K Buy
+3,133
New +$280K 0.12% 283
2025
Q1
Sell
-190
Closed -$17.5K 950
2024
Q4
$17.5K Buy
+190
New +$18.3K 0.02% 944

Other funds holding LMAT

R Squared's LMAT Position: Q2 2026 in Review

R Squared increased its LeMaitre Vascular (LMAT) stake by 9.6% in Q2 2026, buying an estimated $25.2K and bringing the position to 2,817 shares worth $270K. The position accounts for 0.14% of the portfolio, ranked #257.

R Squared first reported a position in LMAT in Q4 2024 and has held it in 5 quarters since. The position peaked at $281K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • R Squared held 2,817 shares of LeMaitre Vascular worth $270K as of Q2 2026.
  • R Squared bought 246 LeMaitre Vascular shares in Q2 2026, an estimated $25.2K.
  • LeMaitre Vascular made up 0.14% of R Squared's portfolio in Q2 2026, its #257 holding.
  • R Squared first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 5 quarters since.
  • R Squared's LeMaitre Vascular position peaked at $281K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.